Qin, Y., Mattern, K. A., Zhang, V., Abe, K., Kim, J., Zheng, M., Gangam, R., Kalinin, A., Kolev, J. N., Axnanda, S., Dance, Z. E. X., Ayesa, U., Ji, Y., Grosser, S. T., Appiah-Amponsah, E., & McMullen, J. P. (2024). Evolution of a green and Sustainable Manufacturing Process for Belzutifan: Part 4─Applications of Process Analytical Technology in heterogeneous biocatalytic hydroxylation. Organic Process Research & Development, 28(2), 432–440. https://doi.org/10.1021/acs.oprd.3c00419
Biocatalytic reactions are advanced through the use of PAT
Scientists at Merck are developing and utilizing biocatalytic-based syntheses in the production of key intermediates in pharmaceutical processes. Biocatalysis has numerous advantages relative to classical chemistry synthesis with the goal of fewer reaction steps, milder catalytic conditions, better cost-effectiveness, and the use of aqueous reaction media, all resulting in an overall improved process sustainability. Though the application of biocatalysis is promising, numerous developmental challenges must be addressed concerning cost, robustness, and scalability.
In the work described in this article, Merck scientists tackle these issues to establish a new route for the drug Belzutifan, which is used in the treatment of renal cancer. They apply biocatalysis in the development of a single-step hydroxylation reaction, which replaces five chemical steps required in the original route [2]. To form the desired hydroxyindanone molecule, indanaone was treated with engineered L-pipecolic acid 4 hydroxylase. Accomplishing this required overcoming specific problems. For example, since the biocatalytic reaction is performed in aqueous media, the reagents and products had variable, limited solubility, and formed slurries. In addition to the physical engineering aspects of handling slurries, reaction kinetics and the ability to acquire representative samples for analysis are significantly affected.
A suite of PAT was used to develop the knowledge necessary for the successful execution of this biocatalytic step, including in-situ FTIR (ReactIR), in-situ imaging (EasyViewer), and in-situ sampling (EasySampler) for offline HPLC measurements. The biocatalytic reactions were performed in an automated laboratory reactor (EasyMax) to ensure precise control of reaction variables. The multi-phase, dense slurries that were required for the manufacturing scale presented significant analytical challenges. Offline sampling was challenging due to sample inhomogeneity, and in-situ sampling was difficult due to clogging. Furthermore, because the hydroxyindanone product precipitates from solution, direct measurement by in-situ FTIR became problematic. To overcome this latter issue, the scientists developed a method to enable in-situ FTIR to measure the soluble succinate by-product, quantitively relate it to hydroxyindanone product formation, and thereby accurately track the reaction progress.
Another interesting, initially poorly understood observation was that the addition of 1-octanol in place of an anti-foam agent substantially improved reaction conversion. EasyViewer imaging studies performed under reaction conditions clearly demonstrated the difference between reactions with and without 1-octanol. These studies revealed that when 1-octanol is absent, the indanone aggregates and forms large particles. When 1-octanol is present, the hydroxyindanone product crystallizes out of solution faster, and the crystals present with different morphology. Furthermore, ReactIR tracking shows that the reaction progresses more rapidly in the presence of the 1-octanol. The studies revealed that these effects likely result from the amphiphilic nature of 1-octanol and its ability to wet the surface of the indanone particles for improved solubility. The particle size of the indanone reagent proved to substantially affect reaction conversion.
In summary, the researchers observed that the PAT used in this work was not only effective for monitoring reaction progress but also provided significant mechanistic insight, thereby enabling the effective development of this biocatalytic reaction